Welltok, which uses gaming and machine learning to help people manage their health, has raised fresh capital as part of an effort to shift the company to be more consumer driven and expand into new market segments, according to a company statement. Update In response to emailed questions, Welltok CEO Jeff Margolis talked about its […]
Healthcare investment conference MidAmerica Healthcare Venture Forum wants to bring active investors and corporate business development executives together to invest in promising Midwest based startups. The event is set for April 22-23 in Chicago. The speaker lineup includes some of the healthcare industry’s most influential and innovative investors, such as Jack Young. He is the director of […]
Dr. Lucian Iancovici is an investment manager at Qualcomm Ventures with a focus on the Qualcomm Life Fund, a $100 million digital health fund. He manages the fund’s investments in Fitbit and PracticeFusion. This week at HIMSS, Iancovici was a keynote speaker at a venture forum to explore investment trends in healthcare and the different […]
One of the issues that emerged from conversations with industry insiders about UnitedHealth’s deal for Audax Health is that it indicates how payers are trying to change themselves so that they can be more competitive in a post-Obamacare world. One payer source observed that as health plans shift from vertically integrated companies, they are trying […]
No more catheter, no more cuff for monitoring patient vital signs? Sotera Wireless announced the FDA has given 510(k) clearance to its continuous non-invasive blood pressure (cNIBP) technology, a new feature of its ViSi Mobile patient monitoring system. “For the first time clinicians can continuously monitor all patient vital signs, including beat-to-beat blood pressure, without the […]
Corporate venture capital may be what fills in the large gaps VC has left behind, with CVC deals about 60 percent larger than VC deals on the whole. Healthcare corporate venture capital deals are up nearly 40 percent compared to Q1 and funding is up 34 percent, according to a report from CB Insights. There were […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Investors may have pumped 45 percent more money into digital health companies in 2012 than they did in 2011, but new data shows most of them are either still apprehensive or haven’t yet found the kind of deals they’re looking for. Rock Health’s year-in-review report on digital health investing delivers insights about investors’ interests in […]
